On November 20, 2024, the Association of Cannabinoid Specialists was joined by Dr. Sandra Carrillo as she presented a symposium on Cannabis and Epilepsy.

https://www.youtube.com/watch?v=jVxEclvhcF0

The webinar, sponsored by the Attorneys and Judges Council and hosted by Hadassah's Professional Councils Chair, Carol Greenfield, features Dr. Jordan Tishler discussing the medical use and legislative landscape of cannabis.

When considering medical cannabis, patients often have numerous questions for their physicians. These questions typically revolve around safety, efficacy, legal issues, and personal concerns. Here are some of the most common questions patients are likely to ask their physicians about medical cannabis:

On June 18, 2024, the Association of Cannabinoid Specialists was proud to host the symposium “Communicating Cannabis Use Before Surgery”, featuring Deondra Asike, MD, double board certified in anesthesiology and pain medicine.  

On May 21, 2024, ACS was joined by Dr. Eugene Vortsman as he discussed the risks associated with cannabis.

Recently there has been a lot of discussion in various states about regulating or banning hemp-derived cannabinoids and intoxicating hemp products.  This has come up in part because these hemp-derived products are circumventing state-legal programs as well as posing public health risk due to lack of regulation.  Let’s take a look at why this is important and also where current focus misses the boat.

In this episode of the Association of Cannabinoids Specialists, host John Malanca is joined by Dr. Jordan Tishler and Dr. Suraj Tandon to discuss the topic of CBD.

Dr. Tandon is a highly accomplished physician from Toronto who specializes in cannabinoid medicine and palliative care.

Topics of this episode of Casual Conversations include contraindications of cannabis use, with focuses on specific ailments such as schizophrenia, liver disease, cardiologic and neurovascular issues, mental health, and drug-drug interactions.

The discussion on this episode of Casual Conversations centers on the safety of drug-to-drug interactions involving cannabis and pharmaceuticals.